This article explores the integration of synthetic biology with actinobacterial research to address the urgent need for novel bioactive compounds in an era of rising antimicrobial resistance.
This article provides a comprehensive overview of the transformative role of synthetic biology in metabolic engineering for researchers, scientists, and drug development professionals.
This article provides a comprehensive overview of the synthetic biology tools and strategies that are transforming the discovery of natural products (NPs) for drug development.
This article provides a comprehensive comparative analysis of systems biology and synthetic biology, two transformative disciplines reshaping biomedical research and therapeutic development.
This article provides a comprehensive overview of the Design-Build-Test-Learn (DBTL) cycle, the core engineering framework of synthetic biology, tailored for researchers and drug development professionals.
This article provides a comprehensive exploration of synthetic biology principles and their transformative impact on biomedical engineering.
This article provides a comprehensive overview of orthogonality as a foundational principle in synthetic gene circuit design, tailored for researchers and drug development professionals. It explores the core concept of creating genetic components that interact strongly with each other while minimizing interference with host cellular processes. The content covers the expanding toolbox of orthogonal regulatory devices, from DNA recombinases to CRISPR-based systems and RNA regulators. It delves into methodological strategies for implementing orthogonality across different organisms and applications, addresses critical challenges in circuit evolutionary stability and performance optimization, and reviews validation frameworks and comparative analyses of orthogonal platforms. By synthesizing the latest advances, this review serves as a guide for designing next-generation genetic circuits with enhanced reliability for biomedical and biotechnological applications.
This article provides a comprehensive overview of modern screening methodologies for functional genetic circuits, targeting researchers, scientists, and drug development professionals. It explores the foundational principles of genetic circuit design, including core architectures and orthogonality. The content details cutting-edge screening platforms such as CRISPR-based perturbomics and single-cell RNA sequencing, alongside diverse applications in metabolic engineering, gene therapy, and stem cell programming. The article further addresses critical troubleshooting strategies for evolutionary instability and burden, while examining validation frameworks and comparative analysis of screening outcomes. This resource serves as both a technical guide and strategic roadmap for implementing genetic circuit screening in research and therapeutic development.
The predictable design of synthetic gene circuits is fundamentally challenged by genetic context effects, where circuit performance is unpredictably modulated by interactions with the host cell. These effects, including metabolic burden, resource competition, and evolutionary instability, lead to lengthy design cycles and hinder clinical and industrial translation. This article provides a comprehensive framework for managing these context effects, exploring their foundational causes, presenting advanced wetware and software design methodologies, detailing troubleshooting and optimization strategies for long-term circuit stability, and validating these approaches through real-world applications in therapy and metabolic engineering. Aimed at researchers and drug development professionals, this review synthesizes the latest advances to guide the development of robust, context-aware genetic systems.
Synthetic transcription factors (synTFs) are engineered proteins that enable precise control over gene expression, offering revolutionary potential for cell reprogramming, gene therapy, and functional genomics. This article provides a comprehensive resource for researchers and drug development professionals, exploring the foundational principles of synTF design—comprising programmable DNA-binding domains and effector modules. It details advanced methodological platforms like CRISPR-based systems and their applications in therapeutic cell engineering, alongside critical troubleshooting considerations for efficacy and safety. The content further covers state-of-the-art validation techniques and comparative analyses of different synTF technologies, synthesizing key insights to outline a path for their clinical translation.